反応式
[P:1]([O:4][CH2:5][C@H:6]1[O:10][C@@H:9]([N:11]2[CH:19]=[C:17]([CH3:18])[C:15](=[O:16])[NH:14][C:12]2=[O:13])[CH2:8][C@@H:7]1[N:20]=[N+:21]=[N-:22])([O-])[O-:2].C([NH+:25](CC)CC)C.C([NH+](CC)CC)C.C[O:38][C:39](=O)[C@H:40]([CH2:42][C:43]1[CH:48]=[CH:47][CH:46]=[CH:45][CH:44]=1)[NH2:41].C(Cl)(Cl)Cl.[CH3:54][OH:55].[OH2:56]>>[CH3:18][C:17]1[C:15](=[O:16])[NH:14][C:12](=[O:13])[N:11]([C@@H:9]2[O:10][C@H:6]([CH2:5][OH:4])[C@@H:7]([N:20]=[N+:21]=[N-:22])[CH2:8]2)[CH:19]=1.[CH3:54][O:55][C:47]1[CH:46]=[CH:45][CH:44]=[C:43]([CH:48]=1)[CH2:42][C@@H:40]([C:39]([O:38][P:1]([NH2:25])(=[O:4])[O-:2])=[O:56])[NH2:41]参加物
4
実験手順
Compound 40 (277 mg, 0.640 mmol) and phenylalanine methyl ester (HCl salt, 276 mg, 1.28 mmol) were subjected to a procedure similar to that described in Example 6. Flash chromatography (SiO2, 5:2:0.25 CHCl3/MeOH/H2O containing 0.5% conc. NH4OH) gave the title compound (216 mg, 64%) as a white solid. 1H NMR (D2O, 300 MHz) 7.424 (s, 1H), 7.120-6.974 (m, 5H), 5.998 (t, J=6.7 Hz, 1H), 4.153 (m, 1H), 3.843 (m, 1H), 3.728 (m, 1H), 3.585 (m, 2H), 3.491 (s, 3H), 2.794 (m, 1H), 2.699 (m, 1H), 2.219 (m, 1H), 2.116 (m, 1H), 1.675 (s, 3H); 31P NMR (D2O, 121 MHz) 6.370; HRMS (FAB m/z calcd for C13H20N6O8P (M+H)+ 419.1080, found 419.1103.
出典と根拠
- ORDレコード
- ord-ef0e099c39734f8e9bb95b022e7b18de
- 出典データセット
- uspto-grants-2002_11
- 特許番号
- US06475985B1
関連ノート
読み込み中…